Advertisement
Pathophysiology| Volume 105, ISSUE 3, SUPPLEMENT 1, 66S-73S, September 28, 1998

Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology?

  • Richard L Bruno
    Correspondence
    Requests for reprints should be addressed to Richard L. Bruno, PhD, The Post-Polio Institute, Englewood Hospital and Medical Center, 350 Engle Street, Englewood, NJ 07631
    Affiliations
    Kids’ Fatigue Management Program, Englewood Hospital and Medical Center, Englewood, New Jersey USA

    The Post-Polio Institute, Englewood Hospital and Medical Center, Englewood, New Jersey, USA

    Harvest Center, Hackensack, New Jersey, USA
    Search for articles by this author
  • Susan J Creange
    Affiliations
    Kids’ Fatigue Management Program, Englewood Hospital and Medical Center, Englewood, New Jersey USA
    Search for articles by this author
  • Nancy M Frick
    Affiliations
    Harvest Center, Hackensack, New Jersey, USA
    Search for articles by this author

      Abstract

      Fatigue is the most commonly reported and most debilitating of post-polio sequelae affecting the >1.8 million North American polio survivors. Post-polio fatigue is characterized by subjective reports of difficulty with attention, cognition, and maintaining wakefulness. These symptoms resemble those reported in nearly 2 dozen outbreaks of post-viral fatigue syndromes (PVFS) that have recurred during this century and that are related clinically, historically, anatomically, or physiologically to poliovirus infections. This article reviews recent studies that relate the symptoms of post-polio fatigue and chronic fatigue syndrome (CFS) to clinically significant deficits on neuropsychologic tests of attention, histopathologic and neuroradiologic evidence of brain lesions, impaired activation of the hypothalamic–pituitary–adrenal axis, increased prolactin secretion, and electroencephalogram (EEG) slow-wave activity. A possible common pathophysiology for post-polio fatigue and CFS, based on the Brain Fatigue Generator Model of PVFS, and a possibile pharmacotherapy for PVFS based on replacement of depleted brain dopamine, will be described.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect